OK Biotech Co., Ltd. (TPE:4155)
Taiwan · Delayed Price · Currency is TWD 16.80
-0.25 (-1.47%)
Oct 30, 2026, 1:30 PM CST
OK Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,537 | 1,556 | 1,670 | 1,192 | 1,484 | 1,263 |
Revenue Growth | -10.54% | -6.81% | 40.11% | -19.65% | 17.42% | -14.89% |
Gross Profit Gross Profit Growth | 478.56 | 429.25 | 275.66 | 196.88 | 344.96 | 186.83 |
Operating Income Operating Income Growth | 220.22 | 107.89 | 57.21 | -12.06 | 101.81 | 8.09 |
Net Income Net Income Growth | 242.24 | 82.45 | 93.98 | 2.95 | 143.46 | 43.46 |
Earnings Per Share EPS Growth | 1.87 | 0.64 | 0.72 | 0.02 | 1.30 | 0.46 |
EPS Growth | - | -11.55% | 3121.00% | -98.28% | 182.57% | -68.83% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Patient Monitoring Equipment Patient Monitoring Equipment Growth | 1,806 | 1,804 | 1,886 | 1,208 | 1,493 | 1,267 |
Intersegment Intersegment Growth | -268.75 | -247.93 | -215.55 | -16.37 | -9.78 | -3.4 |
Total Total Growth | 1,537 | 1,556 | 1,670 | 1,192 | 1,484 | 1,263 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 382.88 | 327.06 | 290.5 | 365.34 | 636.64 | 644.64 |
Total Debt Total Debt Growth | 1,044 | 1,013 | 720.05 | 331.95 | 780.63 | 733.86 |
Net Cash (Debt) Net Cash Growth | -661.02 | -686.09 | -429.55 | 33.39 | -143.98 | -89.22 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.05 | -5.25 | -3.27 | 0.29 | -1.23 | -0.84 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 491.18 | 318.86 | 65.9 | 2.93 | 240.53 | 21.9 |
Capital Expenditures CapEx Growth | -239.94 | -409.14 | -376.69 | -429.68 | -286.84 | -79.06 |
Free Cash Flow Free Cash Flow Growth | 251.23 | -90.28 | -310.79 | -426.74 | -46.31 | -57.16 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.13% | 27.58% | 16.51% | 16.52% | 23.25% | 14.79% |
Operating Margin | 14.33% | 6.93% | 3.43% | -1.01% | 6.86% | 0.64% |
Pretax Margin | 19.07% | 6.67% | 7.61% | 0.67% | 11.84% | 3.65% |
Profit Margin | 15.76% | 5.30% | 5.63% | 0.25% | 9.67% | 3.44% |
FCF Margin | 16.35% | -5.80% | -18.61% | -35.80% | -3.12% | -4.52% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.335 | 0.335 | 0.335 | 0.335 | 1.244 | 1.012 |
Dividend Per Share Growth | 0% | 0% | 0% | -73.11% | 22.94% | -28.57% |
Dividend Yield | 1.99% | 2.07% | 1.43% | 1.20% | 4.63% | 4.28% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.00 | 24.87 | 32.00 | 1240.26 | 18.42 | 51.00 |
Forward PE | - | 16.30 | 16.30 | 16.30 | 16.30 | 16.30 |
PS Ratio | 1.34 | 1.32 | 1.80 | 3.07 | 1.78 | 1.76 |